Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

New Jersey Retina

Neither a doctor nor a teaching hospital

Research payments

$35,950

3 payments

Through program year 2024, New Jersey Retina is reported as receiving $35,950 in research payments, across 3 payments.

By program year

3 rows
Year Kind Amount Payments
2024 Research $523 1
2020 Research $427 1
2019 Research $35,000 1

Breakdown

Who paid Research payments · program years 2019–2024
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $35,427 2 payments
  2. Novartis Pharmaceuticals Corporation $523 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. PoCP NPDR Study, 1 dose vs placebo, 12 wk $35,427 2 payments
  2. A Randomized, Participant and Investigator Masked, Placebo-Controlled, Multicenter, Proof-Of-Concept Study to Assess the Safety and Efficacy of Lnp023 (Iptacopan) in Patients With Early and Intermediate Age-Related MacUlar Degeneration $523 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record